Aurora Cannabis urges shareholders to take no action as Curaleaf yet to file revised bid
ACB•Aurora Cannabis urged shareholders to take no action while Curaleaf has yet to file revised bid terms offering 0.4013 Curaleaf shares and $1.00 cash per Aurora share, or implied consideration of $5.00 per share.
1. Revised bid pending
Aurora’s special committee has not received Curaleaf’s revised filing, delaying its full evaluation and any formal board recommendation. Curaleaf indicated it will add pro forma financial statements and extend the offer expiry to Dec. 4, 2026.
